Glutathione enhances fibroblast collagen contraction and protects keratinocytes from apoptosis in hyperglycaemic culture

British Journal of Dermatology

Volumn 152, Issue 2, 2005, Pages 217-224

  Deveci, M ^a   Gilmont, R R ^b   Dunham, W R ^b   Mudge, B P ^b   Smith, D J ^b   Marcelo, C L ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; Diabetes; Fibroblast contraction; Glutathione; Wound healing

Indexed keywords

GLUTATHIONE;

APOPTOSIS; ARTICLE; CELL POPULATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HYPERGLYCEMIA; KERATINOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; WOUND HEALING;

ANTIOXIDANTS; APOPTOSIS; CELL SIZE; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLASTS; GLUCOSE; GLUTATHIONE; HUMANS; KERATINOCYTES;

EID: 14844302370     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06329.x     Document Type: Article

References (29)

1. Mellin TN, Cashen DE, Ronan JJ et al. Acidic fibroblast growth factor accelerates dermal wound healing in diabetic mice. J Invest Dermatol 1995; 103:850-5.
2. Tomasek JJ, Haaksma CJ, Eddy RJ, Vaughan MB. Fibroblast contraction occurs on release of tension in attached collagen lattices: dependency on an organized actin cytoskeleton and serum. Anat Rec 1992; 232:359-68.
3. Germain L, Jean A, Auger FA, Garrel DR. Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. J Surg Res 1994; 57:268-73.
4. Obara K, Nikcevic G, Pestic L et al. Fibroblast contractility without an increase in basal myosin light chain phosphorylation in wild type cells and cells expressing the catalytic domain of myosin light chain kinase. J Biol Chem 1995; 270:18734-7.
5. Hehenberger K, Heilborn JD, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose associated with increased formation of L-lactate. Wound Repair Regen 1998; 6:135-41.
6. Morocutti A, Sethi M, Hayward A et al. Glutathione reverses the growth abnormalities of skin fibroblasts from insulin-dependent diabetic patients with nephropathy. J Am Soc Nephrol 1998; 9:1060-6.
7. Cheng H, Feldman EL. Bidirectional regulation of p38 kinase and c-jun N-terminal protein kinase by insulin-like growth factor-I. J Biol Chem 1998; 273:14560-5.
8. Baumgartner-Parzer SM, Wagner L, Petterman M et al. High-glucose- triggered apoptosis in cultured endothelial cells. Diabetes 1995; 44:1323-7.
9. Mehlen P, Schulze-Osthoff K, Arrigo A. Small stress proteins as novel regulators of apoptosis. J Biol Chem 1996; 271:16510-14.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
11. Kashiwagi A, Asahina T, Nishiho Y et al. Glycation, oxidative stress, and scavenging activity. Diabetes 1996; 45 (Suppl. 3):S84-6.
12. Shan XQ, Aw TY, Jones DP. Glutathione-dependent protection against oxidative injury. Pharmacol Ther 1990; 47:61-71.
13. Mudge B, Harris C, Rees R. Altered glutathione status in two examples of chronic human wounds. Surg Forum 1998; 49:629.
14. Bell E, Ivarsson B, Merrill C. Production of a tissue like structure by contraction of collagen lattices by human fibroblasts of different differential potential in vitro. Proc Natl Acad Sci USA 1979; 76:1274-8.
15. Marcelo CL, Duel EA, Rhodes LM, Dunham WR. An in vitro model of essential fatty acid deficiency. J Invest Dermatol 1992; 99:771-7.
16. Kuzuya M, Satake S, Ai S et al. Inhibition of angiogenesis on glycated collagen lattices. Diabetologia 1998; 41:491-9.
17. Puolakkainen PA, Twardzik DR, Ranchalis JE et al. The enhancement in wound healing by transforming growth factor-β1 (TGF-β1) depends on the topical delivery system. Ann Surg Res 1995; 58:321-9.
18. Heggers JP, Elzaim H, Garfield R et al. Effect of the combination of Aloe vera, nitroglycerin, and L-NAME on wound healing in the rat excisional model. J Altern Complement Med 1997; 3:149-53.
19. Shukla A, Rasik AM, Patnaik GK. Depletion of reduced glutathione, ascorbic acid, vitamin E and antioxidant defence enzymes in a healing cutaneous wound. Free Radic Res 1997; 26:93-101.
20. Pierce GF, Vande Berg J, Rudolph R et al. Platelet-derived growth factor-bb and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am J Pathol 1991; 138:629-46.
21. Robson MC, Phillips LG, Thomason LE et al. Platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Lancet 1992; 339:23-5.
22. Liechty KW, Nespit M, Herlyn M et al. Adenoviral-mediated overexpression of platelet-derived growth factor-b corrects ischemic impaired wound healing. J Invest Dermatol 1999; 113:375-83.
23. Erlich HP, Cremona O, Gabbiani G. The expression of α2β1 integrin and α-smooth muscle actin in fibroblasts grown on collagen. Cell Biochem Func 1998; 16:129-37.
24. Asaga H, Kukichi S, Yoshizato K. Collagen gel contraction by fibroblasts requires cellular fibronectin but not plasma fibronectin. Exp Cell Res 1991; 193:167-74.
25. Malinda KM, Sidhu GS, Mani H et al. Thymosin β4 accelerates wound healing. J Invest Dermatol 1999; 113:364-8.
26. Asensi M, Sastre J, Pallardo FV et al. Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage. Methods Enzymol 1997; 299:267-76.
27. Urata Y, Yamamoto H, Goto S et al. Long exposure to high glucose concentration impairs the responsive expression of γ-glutamylcystein synthetase by interleukin-1β and tumor necrosis factor-α in mouse endothelial cells. J Biol Chem 1999; 271:15146-52.
28. Finco TS, Beg AA, Baldwin AS. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 1994; 91:11884-8.
29. Nakayama K, Shimizu H, Mitomo K et al. A lymphoid cell-specific nuclear factor containing c-rel-like proteins preferentially interacts with interleukin-6 kappa b-related motifs whose activities are repressed in lymphoid cells. Mol Cell Biol 1999; 12:1736-46.